Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:1.4.3.13 (
lysyl oxidase
)
1,248
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Lysyl oxidase activity in the skin of rats receiving triamcinolone
diacetate
(12 mg/kg) for three consecutive days was decreased by sixty-four percent as compared to control values. A decrease of
lysyl oxidase
activity was observed twelve hours after the initial glucocorticoid injection. The decreased
lysyl oxidase
activity was accompanied by a forty-nine percent decrease of acetic acid extractable collagen. There was also a forty-two percent decrease in the alpha/beta ratio of the acetic acid soluble skin collagen of glucocorticoid-treated animals. These data indicate that although skin
lysyl oxidase
activity is decreased by glucocorticoid treatment, the crosslinking of acid extracted collagen as measured by the alpha/beta ratio and collagen solubility is increased. Accordingly
lysyl oxidase
activity is not rate limiting for collagen crosslink formation in the skins of rats treated with glucocorticoids.
...
PMID:Skin lysyl oxidase activity is not rate limiting for collagen crosslinking in the glucocorticoid-treated rat. 287 Aug 73